.FDA denies psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Permit MDMA Treatment, Seeking Even More Research Study The Nyc TimesFDA Denies Ecstasy-Based Medication The Commercial JournalFDA rejects to permit unfamiliar MDMA therapy to treat post-traumatic stress disorder, with ask for additional trial information CNNFDA declines initially experimental to handle post-traumatic stress disorder, requiring more study The Washington Article.